Senesco Technologies to trade on the American Stock Exchange

New Brunswick, New Jersey
May 14, 2002

Senesco Technologies, Inc. ("Senesco" or the "Company") (OTCBB:SENO) today announced that its application has been conditionally approved for listing on the American Stock Exchange ("AMEX"). Pending the satisfaction of certain initial listing requirements, the Company anticipates commencing trading on AMEX on May 17, 2002, under the ticker symbol "SNT." The Company's shares of common stock have been trading on the OTC Bulletin Board since January 1999.

Bruce Galton, President and CEO of Senesco, stated, "We are pursuing a listing on the American Stock Exchange to provide our shareholders and prospective investors with, what we believe to be, more efficient trading and greater visibility for the Company. We believe these factors will help us toward our goal of increasing shareholder value."

Senesco takes its name from the scientific term for the aging of cells: senescence. The Company has developed technology that regulates the onset of cell death. Delaying cell breakdown in plants extends freshness after harvesting, while increasing crop yields, plant size and resistance to environmental stress for flowers, fruits and vegetables. The Company believes that its technology can be used to develop superior strains of crops without any modification other than delaying natural plant senescence. Senesco has begun to explore ways to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Senesco partners with leading-edge companies and earns research and development fees for applying its gene-regulating platform technology to enhance its partner's products. Senesco is headquartered in New Brunswick, New Jersey, and has research laboratories at the University of Waterloo in Ontario, Canada.

Company news release
4472

OTHER RELEASES FROM THIS COMPANY

Copyright © 2002 SeedQuest - All rights reserved